Extracorporeal removal anti-HLA antibodies transplant candidates results clinical trial transplant candidates extracorporeal immunoadsorption system Protein immunoglobulin plasma dynamics anti-HLA antibody model IgG removal re-equilibration clinical safety procedure end treatment course plasma IgG levels control values contrast albumin levels Specific cytotoxic anti-HLA antibody titers Panel reactivity proportion cell donor panel patients serum presence complement patients significant reduction parameter range follow-up period anti-HLA antibody titers baseline levels remarkable changes blood chemistries unanticipated adverse reactions patients selective extracorporeal immunoadsorption safe effective way IgG-type antibodies potential application reduction HLA antibodies transplant candidates 